SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Beryl Drugs - Quaterly Results

08 Feb 2025 Evaluate
The sales declined to Rs. 54.02 millions for the December 2024 quarter as compared to Rs. 76.61 millions during the corresponding quarter last year.Net profit was down at Rs. 0.52  millions against Rs. 3.10 millions recorded in the corresponding quarter a year ago.The net profit spiraled down by -83.23%.The company reported a degrowth in operating Profit to 5.93 millions from 7.96 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 54.02 76.61 -29.49 173.34 239.17 -27.52 271.25 271.40 -0.06
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 5.93 7.96 -25.50 21.43 26.49 -19.10 26.74 22.35 19.64
Interest 1.20 1.13 6.19 4.51 3.30 36.67 4.64 4.36 6.42
PBDT 4.73 6.83 -30.75 16.92 23.19 -27.04 22.10 17.99 22.85
Depreciation 3.13 3.08 1.62 9.30 8.85 5.08 12.01 8.14 47.54
PBT 1.60 3.75 -57.33 7.62 14.34 -46.86 10.09 9.85 2.44
TAX 1.08 0.65 66.15 3.37 3.17 6.31 2.41 2.18 10.55
Deferred Tax 0.34 -0.46 -173.91 0.00 -1.94 -100.00 -1.98 0.58 -441.38
PAT 0.52 3.10 -83.23 4.25 11.17 -61.95 7.68 7.67 0.13
Equity 50.72 50.72 0.00 50.72 50.72 0.00 50.72 50.72 0.00
PBIDTM(%) 10.98 10.39 5.65 12.36 11.08 11.62 9.86 8.24 19.71

Beryl Drugs Share Price

24.33 -1.20 (-4.70%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×